Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Hybridoma
|
April 22, 1999
Enhancement of antibody dependent cellular cytotoxicity (ADCC) by combination of cytokines
D Flieger, U Spengler, I Beier, et al.
Transplantation
|
April 27, 1994
Allogeneic bone marrow transplantation for recurrence of leukemia after autologous bone marrow transplantation
N Schwella, R Schwerdtfeger, V König, et al.
Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress
|
October 2, 2003
[beta-catenin overexpression in metastasized colorectal carcinoma--an important mechanism in progression of the disease?]
B Mann, A Gratchev, E Riede, et al.
Blood
|
May 1, 1991
A combined approach for purging multidrug-resistant leukemic cell lines in bone marrow using a monoclonal antibody and chemotherapy
M Aihara, Y Aihara, G Schmidt-Wolf, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
January 19, 2017
A Step-by-Step Clinical Approach for the Management of Neuroendocrine Tumours
A Yordanova, H Ahmadzadehfar, M Gonzalez-Carmona, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 20, 2001
Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: a pilot study
U Schlegel, H Pels, A Glasmacher, et al.
British Journal of Cancer
|
March 31, 1999
FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas
B Mann, A Gratchev, C Böhm, et al.
American Journal of Hematology
|
August 1, 2012
Final results of a randomized trial comparing 1, 3, or 6 infusions of Rituximab plus 6 cycles CHOP provide valuable preliminary data towards a more cost-effective and safer treatment of advanced follicular lymphoma
F McClanahan, T Hielscher, M Rieger, et al.
Leukemia
|
June 1, 2017
High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group
B Kasenda, G Ihorst, R Schroers, et al.
Leukemia
|
June 24, 2017
DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemia
V I Gaidzik, D Weber, P Paschka, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Hybridoma
|
April 22, 1999
Enhancement of antibody dependent cellular cytotoxicity (ADCC) by combination of cytokines
D Flieger, U Spengler, I Beier, et al.
Transplantation
|
April 27, 1994
Allogeneic bone marrow transplantation for recurrence of leukemia after autologous bone marrow transplantation
N Schwella, R Schwerdtfeger, V König, et al.
Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress
|
October 2, 2003
[beta-catenin overexpression in metastasized colorectal carcinoma--an important mechanism in progression of the disease?]
B Mann, A Gratchev, E Riede, et al.
Blood
|
May 1, 1991
A combined approach for purging multidrug-resistant leukemic cell lines in bone marrow using a monoclonal antibody and chemotherapy
M Aihara, Y Aihara, G Schmidt-Wolf, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
January 19, 2017
A Step-by-Step Clinical Approach for the Management of Neuroendocrine Tumours
A Yordanova, H Ahmadzadehfar, M Gonzalez-Carmona, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 20, 2001
Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: a pilot study
U Schlegel, H Pels, A Glasmacher, et al.
British Journal of Cancer
|
March 31, 1999
FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas
B Mann, A Gratchev, C Böhm, et al.
American Journal of Hematology
|
August 1, 2012
Final results of a randomized trial comparing 1, 3, or 6 infusions of Rituximab plus 6 cycles CHOP provide valuable preliminary data towards a more cost-effective and safer treatment of advanced follicular lymphoma
F McClanahan, T Hielscher, M Rieger, et al.
Leukemia
|
June 1, 2017
High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group
B Kasenda, G Ihorst, R Schroers, et al.
Leukemia
|
June 24, 2017
DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemia
V I Gaidzik, D Weber, P Paschka, et al.
Page
of 3